Veracyte
VCYT
$19.31
Share price
-0.87%
Change (1 day)
-14.71%
Change (1 year)
Categories
Veracyte (VCYT) - Cash on Hand
Cash on Hand as of December 2023 : $0.21 B
According to Veracyte's latest financial reports the company has $0.21 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Veracyte - Cash on Hand chart (from 2012 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.21 B | 21.02% |
| 2022-12-31 | $0.17 B | 0.95% |
| 2021-12-31 | $0.17 B | -49.29% |
| 2020-12-31 | $0.34 B | 119.29% |
| 2019-12-31 | $0.15 B | 104.27% |
| 2018-12-31 | $77.99 M | 130.13% |
| 2017-12-31 | $33.89 M | -42.77% |
| 2016-12-31 | $59.21 M | 51.52% |
| 2015-12-31 | $39.08 M | 11.62% |
| 2014-12-31 | $35.01 M | -50.84% |
| 2013-12-31 | $71.22 M | 408.64% |
| 2012-12-31 | $14 M | 85.06% |
| 2011-12-31 | $7.56 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Exact Sciences EXAS | $0.77 B | 259.27% | 🇺🇸 USA |
 Myriad Genetics MYGN | $0.14 B | -34.91% | 🇺🇸 USA |
 Biocept
BIOC | $6.63 M | -96.94% | 🇺🇸 USA |